The application of animal models to study the biocompatibility of bicarbonate-buffered peritoneal dialysis solutions  P.M. ter Wee, R.H.J. Beelen, J.

Slides:



Advertisements
Similar presentations
Experimental model: Daily intra-peritoneal instillation of PD solution (Dianeal 3.86%) for 4-5 weeks via mini vascular access port (fig 1) Daily administration.
Advertisements

Urea and nitrogen excretion in pediatric peritoneal dialysis patients
Acid-base profile in patients on PD
Volume 59, Issue 4, Pages (April 2001)
Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model  Siska Mortier, Dirk Faict, Norbert.
Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.
Volume 57, Issue 2, Pages (October 2000)
F.H. Bender, J. Bernardini, B. Piraino  Kidney International 
Iron indices: What do they really mean?
Buffer transport in peritoneal dialysis
Acid-base profile in patients on PD
Volume 70, Pages S38-S43 (November 2006)
Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique.
Use of icodextrin in high transport ultrafiltration failure
D. Teta, M. Maillard, G. Halabi, M. Burnier  Kidney International 
Impact of new dialysis solutions on peritonitis rates
Volume 64, Pages S3-S12 (December 2003)
Incremental peritoneal dialysis: Effects on the choice of dialysis modality, residual renal function and adequacy  G. Viglino, L. Neri, S. Barbieri  Kidney.
Volume 68, Issue 5, Pages (November 2005)
Progression of renal failure and hypertensive nephrosclerosis
Volume 57, Issue 2, Pages (October 2000)
Volume 62, Issue 2, Pages (August 2002)
Volume 63, Issue 1, Pages (January 2003)
Overcoming barriers that inhibit proper treatment of anemia
High volume peritoneal dialysis vs daily hemodialysis: A randomized, controlled trial in patients with acute kidney injury  D.P. Gabriel, J.T. Caramori,
Left ventricular hypertrophy in renal failure
Volume 60, Issue 5, Pages (November 2001)
S.G. John, N.M. Selby, C.W. McIntyre  Kidney International 
F.H. Bender, J. Bernardini, B. Piraino  Kidney International 
D. Batlle, P. Ramadugu, M.J. Soler  Kidney International 
The renin–angiotensin–aldosterone system in peritoneal dialysis: is what is good for the kidney also good for the peritoneum?  Sharon J. Nessim, Jeffrey.
Volume 86, Issue 6, Pages (December 2014)
Volume 73, Pages S5-S17 (April 2008)
Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.
Volume 54, Issue 6, Pages (January 1998)
Ferruh Artunc, Friedhelm Hildebrandt, Kerstin Amann 
Role of vitamin D receptor activators on cardiovascular risk
In vitro biocompatibility performance of Physioneal
B. Li, T. Morioka, M. Uchiyama, T. Oite  Kidney International 
Clifford J. Holmes, Dirk Faict  Kidney International 
Water-only pores and peritoneal dialysis
Microbiology and outcomes of peritonitis in North America
Nephrology Crossword: Peritoneal Dialysis
Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model  Siska Mortier, Dirk Faict, Norbert.
Volume 66, Issue 3, Pages (September 2004)
AGEs in foods: Do they play a role in uremia?
The role of daily dialysis in the control of hyperphosphatemia
Volume 73, Pages S72-S75 (April 2008)
Volume 64, Pages S84-S93 (December 2003)
Connections between vascular calcification and progression of chronic kidney disease: Therapeutic alternatives  Keith A. Hruska, Suresh Mathew, Matthew.
Urea and nitrogen excretion in pediatric peritoneal dialysis patients
Peritoneal dialysis in Mexico
Peter G. Blake, Arsh K. Jain, Sechelle Yohanna  Kidney International 
Volume 70, Pages S84-S90 (November 2006)
Sclerosing encapsulating peritonitis in a 47-year-old woman
Overview of the cellular and molecular basis of kidney fibrosis
Biocompatibility of icodextrin
Volume 59, Issue 4, Pages (April 2001)
Volume 56, Pages S37-S40 (November 1999)
Charles A. Herzog  Kidney International 
American Journal of Kidney Diseases
Anne Van Langendonckt, Ph. D. , Françoise Casanas-Roux, Ph. D
Volume 57, Issue 2, Pages (October 2000)
Shear stress and the endothelium
Strategies for iron supplementation: Oral versus intravenous
The International Pediatric Peritonitis Registry: Starting to walk
E.F. Vonesh, J.J. Snyder, R.N. Foley, A.J. Collins 
Development and differentiation of endothelium
Volume 64, Pages S43-S49 (December 2003)
Adhesion of human endometrial fragments to peritoneum in vitro
Presentation transcript:

The application of animal models to study the biocompatibility of bicarbonate-buffered peritoneal dialysis solutions  P.M. ter Wee, R.H.J. Beelen, J. van den Born  Kidney International  Volume 64, Pages S75-S83 (December 2003) DOI: 10.1046/j.1523-1755.2003.08808.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 Peritoneal fibrosis is quantified by morphometry using electronmicrographs of mesenteries of (A) control and (B) conventional peritoneal dialysis fluid (PDF)-treated rats. Arrows indicate the thickness of the submesothelial extracellular matrix layer. Note the increase in mesenteric width in B. Bar length is 10 μm. Kidney International 2003 64, S75-S83DOI: (10.1046/j.1523-1755.2003.08808.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 2 Light micrograph of abdominal peritoneal wall of a conventional peritoneal dialysis fluid (PDF)-treated rat. Note the occurrence of granulation tissue as depicted by an enormous increase in submesothelial matrix as seen in the van Giesson staining. Kidney International 2003 64, S75-S83DOI: (10.1046/j.1523-1755.2003.08808.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 3 Omental tissue of a conventional peritoneal dialysis fluid (PDF)-treated rat. The mesothelial cells (MC) are partly present, partly lost. On denuded areas, macrophages (indicated by arrows) try to cover the serosal wound. Bar length is 10 μm. Kidney International 2003 64, S75-S83DOI: (10.1046/j.1523-1755.2003.08808.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 4 Graphic representation of the number of milky spots, the size of the milky spots, as well as the total milky spot area, which indicates the percentage of the omental surface that is covered by milky spots.*Heat-sterilized peritoneal dialysis fluid (PDF) vs. the three other groups, P < 0.03; #filter-sterilized PDF vs. heat-sterilized PDF and vs. control, P < 0.03; $lactate buffer vs. heat-sterilized PDF and vs. control, P < 0.03. Reproduced with permission from Zareie et al [23]. Kidney International 2003 64, S75-S83DOI: (10.1046/j.1523-1755.2003.08808.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 5 Graphic representation of the number of omental, mesenteric and abdominal wall vessels. This graph clearly illustrates that the various peritoneal tissues respond differently to the different peritoneal dialysis (PD) solutions. *Heat- and filter-sterilized peritoneal dialysis fluid (PDF) vs. lactate buffer and control, P < 0.04; #heat-sterilized and filter-sterilized PDF and lactate buffer vs. control, P < 0.008; $heat-sterilized PDF vs. control, P < 0.02. Reproduced with permission from Zareie et al [23]. Kidney International 2003 64, S75-S83DOI: (10.1046/j.1523-1755.2003.08808.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 6 Electronmicrographs of omental tissue from rats treated with (A) conventional peritoneal dialysis fluid (PDF) or with (B) bicarbonate/lactate-buffered PDF. Note the dramatic mesothelial cell morphology and the endothelial cell activation in (A), which is not seen in (B). Bar length is 20 μm. Reproduced with permission from the J Am Soc Nephrol[17]. Kidney International 2003 64, S75-S83DOI: (10.1046/j.1523-1755.2003.08808.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 7 Bacterial killing of peritoneal cells recovered from rats after daily instillation of conventional lactate-buffered peritoneal dialysis fluid (PDF) (L) and bicarbonate/lactate-buffered PDF (B/L). C represents the killing of control peritoneal cells. Data are expressed as median and range. Control vs. B/L, P < 0.05; L vs. B/L, P < 0.05. Reprinted with permission from the J Am Soc Nephrol[17]. Kidney International 2003 64, S75-S83DOI: (10.1046/j.1523-1755.2003.08808.x) Copyright © 2003 International Society of Nephrology Terms and Conditions